The text to correct from user michelangelo
Two kinds of transplant are used in the clinical practice: autologous and allogeneic. In the autologous HSCT (auto-HSCT), the graft derives from the patients themselves and there are no problems with the adverse reaction caused by the transplanted immune system. However, when the auto-HSCT is applied to malignant disorders, the disease relapse risk is increased. Conversely, in the allogeneic HSCT (allo-HSCT), the CD-34+ are harvested from a healthy donor and infused in a different patient. In this thesis the concern is on the allo-HSCT, therefore, we will not describe other detail about the auto-HSCT.
Language: English
Language Skills: Native speaker, Proficiency, Advanced
Login or
register to correct this text!
You can correct this text if you set follow language skills of
English in settings:
Native speaker, Proficiency, Advanced
Please correct texts in English:
Please help with translation: